PARIS: French health authorities have reported the first documented human infection with Shamonda virus, an insect-borne pathogen previously known to affect livestock, after a severely immunocompromised patient died in early October.
The case has prompted monitoring by the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC), as scientists investigate how the infection occurred and what it means for public health.
Authorities have stressed that no health risk to the general population has been identified so far. The WHO has also said that, based on current information and knowledge of closely related viruses, the isolated case is unlikely to lead to wider spread at this time.
The death, however, does not establish that Shamonda virus was responsible. The patient had been receiving treatment for a serious underlying illness, and investigators are still examining whether the infection caused or contributed to his death.
What is known about the first human case?
The patient was receiving treatment for a serious illness that left him more susceptible to infection and complications than the general population, according to the ECDC. French authorities described the case as involving severe immunodeficiency.
The man died in early October. Reports identified him as being in his 60s and living in the Lyon area, although authorities have not publicly established that the virus caused his death.
The leading hypothesis is that he acquired the infection after being bitten by an infected Culicoides midge in eastern France, where the virus had circulated among animals during spring and summer 2026.
The specific insect species involved has not been identified, and investigations into the route of infection remain ongoing.
The discovery is significant because Shamonda virus had previously been regarded as an animal virus, with no documented human infections. French authorities said the case represents the first documented detection of the virus in a human internationally.
The findings do not yet establish how readily the virus can infect people, whether infection can cause illness in otherwise healthy individuals or whether human-to-human transmission is possible.
Why are health authorities monitoring the case?
The WHO is in contact with French authorities, while the ECDC is working with European partners to investigate the potential public-health implications and strengthen testing capacity.
The ECDC is also coordinating with the European Commission and the European Food Safety Authority (EFSA), which works on animal health and food safety across the European Union.
The immediate priority is to establish how the patient became infected, determine whether any additional human infections have occurred and assess whether the case signals a change in the virus's behaviour.
The WHO's assessment is reassuring but remains based on the information currently available. A single documented human infection does not, by itself, demonstrate that the virus can spread efficiently among people.
The investigation is therefore important not only for understanding this patient's infection but also for identifying any potential changes in the risk posed by a pathogen that has until now been associated primarily with animals.
What is Shamonda virus?
Shamonda virus is an orthobunyavirus transmitted mainly by biting midges of the genus Culicoides. Cattle are its most common hosts, although infections have also been detected in other animals, including sheep, goats, horses and alpacas.
The virus was first identified in Nigeria in the mid-1960s. Before its emergence in Europe in 2026, it had been reported sporadically in parts of Africa and Japan.
It is genetically related to viruses in the Simbu group, including Schmallenberg virus and Akabane virus, which are associated with disease in livestock.
Unlike many viruses that spread directly between people, Shamonda is primarily associated with transmission through infected insect vectors. French authorities have reported no evidence of significant direct animal-to-animal transmission, apart from possible transmission from an infected mother to her offspring during pregnancy.
The first human case now raises questions about the range of hosts the virus can infect and the circumstances under which human infection may occur. Further investigation will be needed before scientists can draw firm conclusions about its implications.
How widely has the virus spread among European animals?
Shamonda virus was detected in European farm animals for the first time in 2026. Clinical signs in livestock were reported from June, and the virus was identified in late July following investigations into illness among cattle in France and neighbouring countries.
By October 22, the ECDC reported detections in farm animals in Austria, Belgium, France, Germany, Ireland, Italy, Liechtenstein, Luxembourg, the Netherlands, Portugal, Spain and Switzerland, as well as Jersey.
The spread across multiple countries has made the virus an important animal-health concern, even though authorities have not identified a wider public-health risk from the newly reported human infection.
In France, the virus has been associated with illness among cattle, particularly dairy cows. Reported symptoms include fever, diarrhoea, weakness and reduced milk production. The signs are often temporary, but their economic effects can be significant for affected farms.
A study involving nine French dairy farms found that milk production fell by between 15% and 75% in affected herds. Researchers have also investigated possible reproductive effects, including abortions and congenital abnormalities in offspring, although the extent of these effects continues to be studied.
The virus's spread has been linked to the activity of biting midges, whose seasonal patterns vary according to species, location and weather. The ECDC said the activity of most biting midge species in Europe was declining as temperatures cooled in autumn.
Does the case mean the virus is spreading to humans?
Not on the evidence currently available.
The first documented human infection demonstrates that infection can occur, but it does not establish how frequently this happens or whether the virus can sustain transmission among people.
The patient's severe immunodeficiency is an important part of the investigation because it may have made him more vulnerable to infection or complications. Researchers still need to determine whether his case reflects an exceptionally unusual event or a risk that has previously gone undetected.
French authorities have said that no risk to the general population has been identified. The WHO has similarly assessed wider spread as unlikely at this stage, based on current information and knowledge of related viruses.
These assessments may change if investigators identify additional human infections or obtain new evidence about transmission. For now, the available evidence does not support describing Shamonda as a human outbreak.
Is there a risk from milk or meat?
France's Ministry of Agriculture, Food Sovereignty and Food Industries says there is currently no scientific evidence documenting transmission of Shamonda virus through the consumption of meat, milk or their products.
The ministry also states that products from infected animals are excluded from consumption. This is distinct from evidence that eating or drinking animal products transmits the virus: no such transmission has been documented to date.
The virus is primarily associated with infected biting midges, and current animal-health measures focus on reducing exposure to these insect vectors.
There is no vaccine currently available for Shamonda virus in animals, according to the French ministry, and no specific antiviral treatment is available to eliminate the virus in infected livestock.
What happens next?
French authorities and European health agencies are continuing clinical, biological and epidemiological investigations into the human case. The ECDC is working with European partners and a relevant EU reference laboratory to strengthen testing capacity and support efforts to identify any additional infections.
Scientists will need to clarify how the patient acquired the virus, whether the infection contributed to his death and whether other human infections have gone undetected.
The case also highlights the importance of monitoring diseases at the intersection of human, animal and environmental health. A pathogen circulating among livestock may warrant closer investigation when new evidence suggests it can infect humans, even if the immediate public-health risk remains low.
For now, health authorities are treating the case as an exceptional event rather than evidence of a wider outbreak. The central question is whether further investigation confirms that it was an isolated infection or reveals a broader pattern that requires a different public-health response.
Stay informed with Medical News Pakistan
CLICK HERE TO FOLLOW Medical News Pakistan WhatsApp Channel for important medical news, research breakthroughs and professional updates.